Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka, et al.
Hepatology (2017) Vol. 67, Iss. 6, pp. 2141-2149
Closed Access | Times Cited: 220

Showing 51-75 of 220 citing articles:

Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent Wai‐Sun Wong, Mary E. Rinella, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access | Times Cited: 1
Epidemiology of Alcohol Use and Alcoholic Liver Disease
Jessica L. Mellinger
Clinical Liver Disease (2019) Vol. 13, Iss. 5, pp. 136-139
Open Access | Times Cited: 74
Alcohol Rehabilitation Within 30 Days of Hospital Discharge Is Associated With Reduced Readmission, Relapse, and Death in Patients With Alcoholic Hepatitis
Thoetchai Peeraphatdit, Patrick S. Kamath, Victor M. Karpyak, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 2, pp. 477-485.e5
Open Access | Times Cited: 73
Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Meng-Wei Xiao, Shixin Lin, Zhaohua Shen, et al.
Gastroenterology Research and Practice (2019) Vol. 2019, pp. 1-19
Open Access | Times Cited: 69
Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis
Mads Israelsen, Helene Bæk Juel, Sönke Detlefsen, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 20, Iss. 8, pp. 1784-1794.e9
Open Access | Times Cited: 66
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Theresa Hydes, Sujan Ravi, Rohit Loomba, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 383-400
Open Access | Times Cited: 63
Combined alcoholic and non-alcoholic steatohepatitis
Line Carolle Ntandja Wandji, Viviane Gnemmi, Philippe Mathurin, et al.
JHEP Reports (2020) Vol. 2, Iss. 3, pp. 100101-100101
Open Access | Times Cited: 62
Periodontitis is associated with incident chronic liver disease—A population‐based cohort study
Jaana Helenius‐Hietala, Anna Liisa Suominen, Hellevi Ruokonen, et al.
Liver International (2018) Vol. 39, Iss. 3, pp. 583-591
Open Access | Times Cited: 60
Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions
Fredrik Åberg, Martti Färkkilâ
Seminars in Liver Disease (2020) Vol. 40, Iss. 02, pp. 154-162
Open Access | Times Cited: 60
The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
Jong Hwa Choi, Won Sohn, Yong Kyun Cho
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 662-669
Open Access | Times Cited: 52
Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment
Anna De Filippis, Hammad Ullah, Alessandra Baldi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4929-4929
Open Access | Times Cited: 50
Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway
Jinqiu Zhao, Bin He, Shujun Zhang, et al.
International Journal of Medical Sciences (2021) Vol. 18, Iss. 6, pp. 1382-1389
Open Access | Times Cited: 46
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 2, pp. 265-274
Open Access | Times Cited: 44
Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
Stephen Malnick, Pavel Alin, Marina Somin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16226-16226
Open Access | Times Cited: 37
The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Yasser Fouad, Gamal Esmat, Reda Elwakil, et al.
Saudi Journal of Gastroenterology (2022) Vol. 28, Iss. 1, pp. 3-20
Open Access | Times Cited: 32
Alcohol use disorder in community management of chronic liver diseases
Lorenzo Leggio, Jessica L. Mellinger
Hepatology (2022) Vol. 77, Iss. 3, pp. 1006-1021
Open Access | Times Cited: 31
Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals
Maria Kjærgaard, Katrine Prier Lindvig, Katrine Thorhauge, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 5, pp. 1037-1047.e9
Open Access | Times Cited: 20
Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE Score
Pimsiri Sripongpun, Apichat Kaewdech, Prowpanga Udompap, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101127-101127
Open Access | Times Cited: 7
The characteristics and risk factors of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis
Maki Tobari, Etsuko Hashimoto, Makiko Taniai, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 5, pp. 862-869
Closed Access | Times Cited: 53
Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies
Fredrik Åberg, Martti Färkkilâ, Ville Männistö
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 2, pp. 384-403
Closed Access | Times Cited: 43
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)
Michael Johnston, Janisha Patel, Christopher D. Byrne
Current Pharmaceutical Design (2020) Vol. 26, Iss. 10, pp. 1079-1092
Open Access | Times Cited: 42
Bariatric surgery and the risk of alcohol‐related cirrhosis and alcohol misuse
Jessica L. Mellinger, Kerby Shedden, Gerald Scott Winder, et al.
Liver International (2021) Vol. 41, Iss. 5, pp. 1012-1019
Open Access | Times Cited: 36
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
Mads Israelsen, Min Kim, Tommi Suvitaival, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100325-100325
Open Access | Times Cited: 36
Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
C. Wendy Spearman, Mary Afihene, Omolade Betiku, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 12, pp. 1036-1046
Closed Access | Times Cited: 35
The role of alcohol use in the aetiology and progression of liver disease: A narrative review and a quantification
Jürgen Rehm, Jayadeep Patra, Alan Brennan, et al.
Drug and Alcohol Review (2021) Vol. 40, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 32

Scroll to top